Nucera, C. (2019). A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer. Oncotarget.
Style de citation ChicagoNucera, Carmelo. "A Novel Combined Targeted Therapy With Bromodomain Antagonist and MEK Inhibitor in Anaplastic Thyroid Cancer." Oncotarget 2019.
Style de citation MLANucera, Carmelo. "A Novel Combined Targeted Therapy With Bromodomain Antagonist and MEK Inhibitor in Anaplastic Thyroid Cancer." Oncotarget 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.